Mayo Clinic Uses Phenomix AI to Predict GLP-1 Side Effects

Read More »

May 8, 2025

Knight Therapeutics Announces Relaunch of ONICIT in Brazil and Mexico

Read More »

May 7, 2025

CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code for Otulfi

Read More »

April 29, 2025

Alcyone Secures Funding to Advance Pediatric Neuro Therapies

Read More »

April 24, 2025

Provista and Coral Partner to Optimize Pharmacy and Infusion Costs

Read More »

April 21, 2025

Chime, Polpharma Partner to Boost Biosimilar Development

Read More »

April 16, 2025

Hoth Therapeutics Announces Positive Initial Data in Phase 2a Clinical Trial

Read More »

April 15, 2025

Verve Reports Positive Heart-2 Trial Data for VERVE-102

Read More »

April 14, 2025

Sandoz Sues Amgen Over Etanercept Biosimilar Access in US

Read More »

April 14, 2025

Synthego and Vita Therapeutics License hfCas12Max CRISPR

Read More »

April 8, 2025

Biotia and Mayo Clinic Collaborate on Infectious Disease Diagnostics

Read More »

April 2, 2025

Artis BioSolutions Emerges from Stealth, Announces Acquisition of Landmark Bio

Read More »

April 2, 2025